(Q49073055)

18 February 2018

title

Successful immunoglobulin treatment in a patient with neuromyotonia. (English)

1 reference

18 February 2018

author name string

Alessi G

1

1 reference

18 February 2018

De Reuck J

2

1 reference

18 February 2018

De Bleecker J

3

1 reference

18 February 2018

Vancayzeele S

4

1 reference

18 February 2018

publication date

1 September 2000

1 reference

18 February 2018

Clinical Neurology and Neurosurgery

published in

1 reference

18 February 2018

volume

102

1 reference

18 February 2018

issue

3

1 reference

18 February 2018

page(s)

173-175

1 reference

18 February 2018

AAEM minimonograph #44: diseases associated with excess motor unit activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Penicillamine-induced neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs' syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900093-7

7 January 2021

10.1016/S0303-8467(00)00093-7

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018